246
Participants
Start Date
May 12, 2020
Primary Completion Date
December 7, 2021
Study Completion Date
January 7, 2022
AndroGel 1.62%
AndroGel 1.62% was packaged in pump bottles with quantities sufficient to accommodate study design and could have been dose adjusted between a minimum of 20.25 mg of T (1 pump actuation) and a maximum of 81.0 mg of testosterone (4 pump actuations). For the first study drug administration at the Day 1 Visit, and also at Week 2, Week 4, Week 16 ambulatory blood pressure monitoring (ABPM,) and End of Treatment Visits, participants applied the study drug while on site so that the site staff could observe the proper administration of study drug. If participants forgot to apply their AndroGel 1.62% dose at their regularly scheduled dosing time, they were to take the next dose at the next dosing time.
AccuMed Research Associates /ID# 216775, Garden City
Frontier Clinical Research /ID# 216365, Smithfield
Centennial Medical Group /ID# 216340, Elkridge
Randolph Health Internal Medicine /ID# 216366, Asheboro
Triad Clinical Trials /ID# 216792, Greensboro
OnSite Clinical Solutions, LLC /ID# 216279, Charlotte
OnSite Clinical Solutions, LLC /ID# 216368, Charlotte
Lucas Research /ID# 216487, Morehead City
North Georgia Clinical Research /ID# 216864, Woodstock
Care Partners Clinical Research /ID# 216773, Jacksonville
Pharmax Research Clinic /ID# 216343, Miami
Care Research center Inc. /ID# 216367, Miami
Invesclinic, U.S., LLC /ID# 216778, Fort Lauderdale
G & L Research, LLC /ID# 216793, Foley
New Phase Research & Development /ID# 216774, Knoxville
Clinical Neuroscience Solutions - Memphis /ID# 216790, Memphis
Diabetes and Endocrinology Associates of Stark County Inc /ID# 216362, Canton
Iowa Diabetes and Endocrinology Research Center /ID# 216316, West Des Moines
Loretto Hospital.Affnity Clinical Research Institute /ID# 216884, Chicago
PRN Professional Research Network of Kansas, LLC /ID# 216805, Wichita
Intend Research /ID# 216320, Norman
Arlington Family Research Center, Inc /ID# 216363, Arlington
FMC Science /ID# 216318, Lampasas
Northwest Houston Clinical Research PLLC /ID# 216358, Tomball
Discovery Clinical Trials-San Antonio /ID# 216866, San Antonio
Lynn Institute of Denver /ID# 216863, Aurora
Solaris Clinical Research /ID# 216772, Meridian
NM Clinical Research & Osteoporosis Center, Inc /ID# 216808, Albuquerque
Advanced Biomedical Research of America /ID# 216797, Las Vegas
West Coast Research LLC /ID# 216813, San Ramon
NewportNativeMD, Inc. /ID# 216992, Newport Beach
Valley Renal Medical Group Research /ID# 216321, Northridge
Innovative Research of West Florida /ID# 216364, Clearwater
Seidman Clinical Trials,Delray /ID# 216794, Delray Beach
Indago Research and Health Cen /ID# 216319, Hialeah
West Orange Endocrinology /ID# 217106, Ocoee
Affinity Clinical Research /ID# 216807, Oak Brook
Investigative Clinical Research of Indiana, LLC /ID# 216943, Elwood
The Research Grp of Lexington /ID# 216451, Lexington
Amici Clinical Research /ID# 216779, Warren Township
Tristar Clinical Investigations PC /ID# 216944, Philadelphia
Associates in Medicine, P.A. /ID# 216781, Houston
Burke Internal Medicine & Research /ID# 216322, Burke
Manassas Clinical Research Center /ID# 216313, Manassas
Virginia Research Center /ID# 216341, Midlothian
Lead Sponsor
AbbVie
INDUSTRY